This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Treatment of Antidepressant Nonresponders: Augmentation or Switch?

J. Craig Nelson, M.D.

Published: June 1, 1998

Article Abstract

Selective serotonin reuptake inhibitors (SSRIs) are now commonly used in the treatment of majordepression. In all patients starting treatment, the intent-to-treat response rate is about 50%. The other50% will require some change in treatment, either augmentation or switch to a different agent. In thisreport, augmentation strategies are reviewed, with special attention to those strategies that have beenused with the SSRIs. The data for switching antidepressants also are reviewed. Although there are nodirect comparison studies of augmentation strategies versus switching that address the question of relativeefficacy, the tactical issues that pertain to augmentation or switching are discussed.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: